Trials / Completed
CompletedNCT01613534
Combined Therapy in Radiation Proctopathy
Argon Plasma Coagulation Plus Placebo or Oral Sucralfate for Chronic Radiation Proctopathy: a Randomized Placebo Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Maria Sklodowska-Curie National Research Institute of Oncology · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to compare the efficacy and safety of two treatment regimens: argon plasma coagulation (APC) alone and APC in combination with sucralfate administered for chronic hemorrhagic radiation proctopathy.
Detailed description
Chronic radiation proctopathy (CRP) or proctosigmoiditis is a late complication of pelvic radiotherapy. Symptoms, including diarrhea, rectal bleeding, urgency, and tenesmus, are difficult to treat and adversely impact patient quality of life. Various treatments directed at the reduction of blood loss and improvement of other symptoms have been evaluated, with the most encouraging results reported for two methods: endoscopic argon plasma coagulation (APC) of radiation-induced abnormal vessels in the rectal mucosa, and administration of sucralfate, a drug believed to enhance the mucosal defense and healing when administered orally or rectally. Adequately powered randomized trials comparing various treatments are lacking, and an optimal management strategy has yet to be determined. To address this issue, we conducted a single-center, randomized, placebo-controlled, double-blind study comparing the efficacy and safety of APC alone and APC in combination with sucralfate administered orally.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sucralfate | Argon plasma coagulation treatment followed by oral sucralfate (6 grams b.i.d.) for four weeks |
| DRUG | Placebo | Argon plasma coagulation treatment followed by placebo administration for four weeks |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2012-06-07
- Last updated
- 2012-06-07
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT01613534. Inclusion in this directory is not an endorsement.